Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
Sialorphin TFA
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Sialorphin TFA is an inhibitor of neutral endopeptidase (NEP) and aminopeptidase N (APN), which is responsive to androgen signaling. It inhibits the degradation of endogenous opioid peptides, interacting with μ-, δ-, and κ-opioid receptors. Sialorphin TFA modulates the ERK/mTOR signaling pathway by inducing cell cycle arrest, enhancing ERK1/2 activity, and reducing phosphorylation levels of mTOR, 4E-BP1, and p70S6K, thereby exhibiting antiproliferative activity against colorectal cancer, glioma, and prostate cancer cells without cytotoxicity. Additionally, it possesses anti-nociceptive properties, regulates sexual behavior, relaxes penile corpus cavernosum smooth muscle, and alleviates experimental colitis. Moreover, Sialorphin TFA serves as a copper (II) ion-binding ligand and has been utilized in mechanistic studies related to cancer, pain management, and inflammatory bowel disease. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.